BPC-157 vs Hexarelin
A comprehensive, data-driven comparison of BPC-157 (Body Protection Compound-157) and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | BPC-157 Body Protection Compound-157, PL 14736 | Hexarelin Examorelin |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Recovery & Healing | Growth Hormone |
| Primary Use | Tissue healing and injury recovery | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $50 - $120/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 250-500mcg daily | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | Daily | Daily |
| Mechanism | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Hexarelin is generally more affordable ($40 - $80/mo) compared to BPC-157 ($50 - $120/mo).
- 2BPC-157 has low-quality evidence, while Hexarelin has emerging-quality evidence.
- 3They belong to different categories: BPC-157 (Recovery & Healing) vs Hexarelin (Growth Hormone).
Which Is Better For...
Hexarelin
More budget-friendly option with lower monthly costs
BPC-157
Fewer commonly reported side effects
BPC-157
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
BPC-157 typically costs $50 - $120/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
BPC-157 is not FDA-approved (Category 2 (pending reclassification)). Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
BPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between BPC-157 and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.